PCSA Stock Analysis: Buy, Sell, or Hold?
PCSA - Processa Pharmaceuticals, Inc. Common
$2.13
-0.02 (-0.93%)
▼
5d:
-17.76%
30d:
-1.39%
90d:
-16.47%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 06, 2026
1d
Get Alerted When PCSA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PCSA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: PCSA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: PCSA is currently trading at $2.13, which is considered slightly low relative to its 30-day fair value range of $1.89 to $2.50.
Technical Outlook: Technically, PCSA is in a downtrend. Immediate support is located at $1.80, while resistance sits at $3.11.
Market Sentiment: PCSA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $25.00 (+1073.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PCSA is in a downtrend. Immediate support is located at $1.80, while resistance sits at $3.11.
Market Sentiment: PCSA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $25.00 (+1073.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.89 -
$2.50
Company Quality Score
42/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: Trading 1073.7% below Wall St target ($25.00)
- CAUTION: 5-day price weakness (-17.8%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$1.89 -
$2.50
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.80
Resistance Level
$3.11
Current Trend
Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.57
Wall Street Target
$25.00
(+1073.7%)
Share & Embed Analysis
Last updated: August 03, 2026 11:45 PM ET
Data refreshes hourly during market hours. Next update: 12:45 AM
Data refreshes hourly during market hours. Next update: 12:45 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PCSA showing a specific setup today?
Insider Activity (6 Months)
12
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
David Young
BUY
1545 shares
2026-04-15
George K Ng
BUY
1843 shares
2026-04-15
Russell Skibsted
BUY
1984 shares
2026-04-15
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$87 | 53 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$196 | 47 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$557 | 49 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 60 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 47 HOLD |
